Insiders Updates
BioNTech SE ADR (BNTX) rating initates by Citigroup
BioNTech SE ADR’s recent filing unveils that its Director Jeggle Helmut Wolfgang acquired Company’s shares for reported $14.21 million on
Menu
BioNTech SE ADR’s recent filing unveils that its Director Jeggle Helmut Wolfgang acquired Company’s shares for reported $14.21 million on
BioNTech SE ADR’s recently made public that its Officer Richardson Ryan acquired Company’s shares for reported $3.02 million on Feb
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Biopharmaceutical New Technologies Inc. (NASDAQ: BNTX) stock declined by 8.64% in the current market trading session. Biopharmaceutical New Technologies is